Is ‘Value for Money’ the Best Approach for Weak Health Systems?

Key Note, David Evans, Director of Health Systems Financing, World Health Organization, Switzerland


Session 1: Linking Governance with Value for Money in Weak Countries


The German BACKUP Model – Potentials and Challenges of Making Global Health Financing More Effective, Anna-Maria von Roda, BACKUP Initiative, Germany


Value for Money in a Rapidly Evolving Aid Landscape, Jacques Mader, SDC, Switzerland


Global Strategies and Local Contexts: Value for Money and Sustainability - Some Lessons from Asia, Peter Godwin, Independent Consultant, India


Session 2: Strengthening the Health Commodity Supply Chain


Pooled Procurement – Experiences Based on ARV and ACT for 52 Countries: One of the Building Blocks for Efficient Health System Strengthening and Value for Money, Luuk Jan Boon, i+Solutions, the Netherlands


The Health System Challenge of Broken Supply Chains, Don de Savigny, Swiss TPH, Switzerland


Is a Compact Pre-filled Auto-disable Injection System (cPAD) for Pentavalent Vaccines More Value for Money?, Patrick Hanlon, Swiss TPH, Switzerland


Strengthening the Supply Chain for Key Medicines to Treat HIV and TB: UNITAID’s Experience, Dr. Kathleen Louise Strong, UNITAID, Switzerland


Session 3: Every Dollar Counts - Measuring the Results


More Health for the Money, Victoria Fan, Center for Global Development, USA


Performance Based Financing: 6 Building Blocks, Jennie van de Weerd, CORDAID, the Netherlands


Performance Based Funding, Improving "Value for Money“, to Save More Lives - A Swiss TPH Experience, Bruno Lab, Swiss TPH, Switzerland


Optimizing Resource Allocation for Global Impact on HIV/AIDS, Tuberculosis and Malaria, Carol D'Souza and Shufang Zhang, Global Fund, Switzerland


Can We Really Compare Cost-Effectiveness Measures? Or – Which Fruit Salad Recipe is Better?, Amy Ratcliffe, PSI, the Netherlands


Abstract only (presentation not available)

Counting Every Dollar? The Role of Audit in Providing Assurance Over Multi-Billion Dollar Investments in Public Health, Elmar Vinh-Thomas/Martin O’Malley, Inspector General,  Global Fund, Switzerland


Outlook and Closing Remarks, Kaspar Wyss, Deputy Director, Swiss TPH Centre for International Health, Switzerland